000739:SHE
Apeloa Pharmaceutical Co Ltd
CNÂ¥19.82
arrow_downward
-0.30%(-0.060) 1D
Nov 17, 3:04:51 PM GMT+8 · CNY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 000739...
Open
CNÂ¥19.74
High
CNÂ¥20.08
Low
CNÂ¥19.64
Mkt. cap
23.03B
Avg. vol.
16.25M
Volume
6.01M
Dividend
1.90%
Quarterly dividend
CNÂ¥0.09
Ex-dividend date
Oct 8, 2026
P/E ratio
28.46
52-wk high
CNÂ¥28.50
52-wk low
CNÂ¥15.19
EPS
CNÂ¥0.70
Shares outstanding
1.16B
No. of employees
7K
Open
CNÂ¥19.74
High
CNÂ¥20.08
Low
CNÂ¥19.64
Mkt. cap
23.03B
Avg. vol.
16.25M
Volume
6.01M
Dividend
1.90%
Quarterly dividend
CNÂ¥0.09
Ex-dividend date
Oct 8, 2026
P/E ratio
28.46
52-wk high
CNÂ¥28.50
52-wk low
CNÂ¥15.19
EPS
CNÂ¥0.70
Shares outstanding
1.16B
No. of employees
7K
News stories
From web sources and news partners
Nieuws.nl
·
7 hours ago
AEX-index daalt verder in afwachting van Nvidia-cijfers
ZeelandNet, startpagina van Zeeland
·
6 hours ago
AEX-index verder omlaag, focus op kwartaalresultaten Nvidia
Nieuws.nl
·
1 day ago
AEX-index start belangrijke week voor AI-sector
ChartMill
·
41 minutes ago
S&P 500 Stocks Gapping Down in Today's Session
Profile
Apeloa Pharmaceutical Co., Ltd., known as Apeloa, is a Chinese pharmaceutical manufacturer under Hengdian Group. The company is headquartered in Hengdian, Dongyang, Zhejiang, China. It was founded in 1989 and has been listed on the Shenzhen Stock Exchange since 9 May 1997. Apeloa provides contract development and manufacturing services and manufactures APIs and finished dosage forms; products span cardiovascular, anti-infective, psychiatric and oncology areas.
Apeloa has 7400 employees, 8 manufacturing sites and 3 R&D centers in Boston, Shanghai and Hengdian, covering flow chemistry, synthetic biology and biocatalysis, and peptide development. It has invested over USD20 million in flow chemistry over the past ten years in an effort to advance sustainable pharmaceutical manufacturing. In Boston, its 17,000-square-foot facility does R&D related to chemistry needs in drug development, including preclinical chemistry, scale-up production and new drug development.
Apeloa Pharmaceutical has successfully passed 20 U.S. FDA inspections since 2006. Wikipedia
About Apeloa Pharmaceutical Co Ltd
CEO-
Employees6.79K
Founded1989
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteapeloa.com